Psychoactive drug use and substance-induced psychosis: Emerging challenges in a low-middle-income country
Therapeutic Advances in Psychopharmacology · 2026-08 · 16
DOI: 10.1177/20451253261473921 ↗Kurz gefasst
Leserbrief in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 16.08.2026. Verfasst von Nabin Pathak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Madan Bhandari Academy of Health Sciences, Bagmati, Nepal. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Plain language summary The Ministry of Home Affairs, Nepal , “The National Master Plan on Prevention and Control of Narcotic Drugs 2012-2019″ reports that cannabis accounts for the highest prevalence of initial narcotic drug use (80.4%), followed by diazepam (9.4%). Narcotic drug users increased by 5.06% annually over the seven-year period, with most users initiating use below the age of 19, posing a significant challenge for drug-induced psychosis. Health policies also influence the use of psychoactive agents. With growing calls for cannabis legalisation in Nepal, policymakers must carefully consider evidence from high-income countries, including the associated public health and mental health consequences. The 12-directive Mandamus issued by the Supreme Court of Nepal for individuals with mental health conditions represents a pivotal step in strengthening mental health in Nepal. It focuses on upholding mental health rights under the constitution and aligning national policies and regulations with international human rights treaties. Effective mental health care requires multidisciplinary teams comprising psychiatrists, psychologists, psychiatric nurses, psychotherapists, and pharmacists.
Autor:innen und Institutionen
- Department of Pharmacy, Madan Bhandari Academy of Health Sciences, Bagmati, Nepal.
- Department of Pharmacy, Drug Information Unit and Pharmacovigilance Cell, Hetauda Hospital, Madan Bhandari Academy of Health Sciences, Bagmati, Nepal.
- Department of Research and Academics, Kathmandu Cancer Center, Tathali, Nala Road, Bhaktapur, Nepal.
- Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.
ORCID-Profile: Nabin Pathak, Sunil Shrestha
Zitieren
APA
Pathak, N., & Shrestha, S. (2026). Psychoactive drug use and substance-induced psychosis: Emerging challenges in a low-middle-income country. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261473921
Vancouver
Pathak N, Shrestha S. Psychoactive drug use and substance-induced psychosis: Emerging challenges in a low-middle-income country. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261473921
BibTeX
@article{Pathak2026,
author = {Pathak, Nabin and Shrestha, Sunil},
title = {Psychoactive drug use and substance-induced psychosis: Emerging challenges in a low-middle-income country},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261473921}
}
EUVIMED